KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Research & Development (2016 - 2025)

Incyte's Research & Development history spans 16 years, with the latest figure at $611.4 million for Q4 2025.

  • For Q4 2025, Research & Development rose 31.19% year-over-year to $611.4 million; the TTM value through Dec 2025 reached $2.1 billion, down 21.36%, while the annual FY2025 figure was $2.1 billion, 21.36% down from the prior year.
  • Research & Development reached $611.4 million in Q4 2025 per INCY's latest filing, up from $506.6 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.1 billion in Q2 2024 to a low of $306.9 million in Q1 2021.
  • Average Research & Development over 5 years is $466.4 million, with a median of $433.3 million recorded in 2024.
  • Peak YoY movement for Research & Development: crashed 71.72% in 2021, then surged 184.06% in 2024.
  • A 5-year view of Research & Development shows it stood at $472.8 million in 2021, then increased by 6.03% to $501.4 million in 2022, then fell by 11.34% to $444.5 million in 2023, then rose by 4.85% to $466.0 million in 2024, then skyrocketed by 31.19% to $611.4 million in 2025.
  • Per Business Quant, the three most recent readings for INCY's Research & Development are $611.4 million (Q4 2025), $506.6 million (Q3 2025), and $494.9 million (Q2 2025).